No price history available.

Based on consensus from external analysts. Not Kvantra's opinion.

Established in 1937 and headquartered in Ballerup, Denmark, Ambu A/S is a global medical technology company specializing in the design, manufacture, and sale of advanced medical devices. The company serves hospitals, clinics, and emergency services worldwide, providing essential healthcare solutions across key disciplines such as visualization, anesthesia, and patient monitoring and diagnostics. Their extensive product portfolio includes sophisticated endoscopy equipment like bronchoscopes and dedicated monitors. For neurology, Ambu offers EEG and EMG electrodes, as well as tools for EMG-guided injections and intraoperative monitoring systems. Cardiology solutions feature ECG electrodes. A substantial portion of their offerings is dedicated to airway management and anesthesia, comprising specialized bronchoscopes, video laryngoscopes, various intubation tubes (double and single lumen), endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitation devices. Additionally, Ambu provides critical emergency and training products, including extrication collars, CPR breathing barriers, and training manikins.

• Double Medical Technology Inc.
• TransMedics Group, Inc.
• Butterfly Network, Inc.
• AxoGen, Inc.
• Medacta Group S.A.
• UFP Technologies, Inc.
• Shanghai MicroPort MedBot (Group) Co., Ltd.
• Lepu Medical Technology (Beijing) Co., Ltd.